Agilent Technologies, Inc. (NYSE:A) Shares Acquired by Kathmere Capital Management LLC

Kathmere Capital Management LLC lifted its position in Agilent Technologies, Inc. (NYSE:A) by 18.4% in the fourth quarter, Holdings Channel reports. The firm owned 3,010 shares of the medical research company’s stock after acquiring an additional 468 shares during the period. Kathmere Capital Management LLC’s holdings in Agilent Technologies were worth $404,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also recently added to or reduced their stakes in the company. McAdam LLC grew its position in Agilent Technologies by 3.1% during the 3rd quarter. McAdam LLC now owns 2,531 shares of the medical research company’s stock worth $376,000 after purchasing an additional 77 shares during the last quarter. Brown Brothers Harriman & Co. grew its holdings in shares of Agilent Technologies by 13.5% during the third quarter. Brown Brothers Harriman & Co. now owns 646 shares of the medical research company’s stock worth $96,000 after buying an additional 77 shares during the last quarter. Global Retirement Partners LLC increased its position in Agilent Technologies by 3.2% in the 3rd quarter. Global Retirement Partners LLC now owns 2,570 shares of the medical research company’s stock valued at $382,000 after acquiring an additional 79 shares during the period. Rovin Capital UT ADV raised its stake in Agilent Technologies by 1.6% during the 3rd quarter. Rovin Capital UT ADV now owns 5,049 shares of the medical research company’s stock valued at $750,000 after acquiring an additional 81 shares during the last quarter. Finally, Marshall Financial Group LLC lifted its position in Agilent Technologies by 1.0% during the 3rd quarter. Marshall Financial Group LLC now owns 8,243 shares of the medical research company’s stock worth $1,224,000 after acquiring an additional 82 shares during the period.

Agilent Technologies Price Performance

A stock opened at $144.77 on Friday. The firm has a 50 day moving average of $136.16 and a 200-day moving average of $136.99. The company has a market cap of $41.35 billion, a price-to-earnings ratio of 32.75, a PEG ratio of 3.71 and a beta of 1.06. The company has a current ratio of 2.09, a quick ratio of 1.58 and a debt-to-equity ratio of 0.57. Agilent Technologies, Inc. has a 12-month low of $124.16 and a 12-month high of $155.35.

Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Monday, November 25th. The medical research company reported $1.46 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.41 by $0.05. The firm had revenue of $1.70 billion during the quarter, compared to analysts’ expectations of $1.67 billion. Agilent Technologies had a return on equity of 25.43% and a net margin of 19.80%. Agilent Technologies’s revenue was up .8% on a year-over-year basis. During the same period in the previous year, the firm posted $1.38 earnings per share. As a group, equities analysts expect that Agilent Technologies, Inc. will post 5.56 EPS for the current fiscal year.

Agilent Technologies Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 22nd. Shareholders of record on Tuesday, December 31st will be issued a dividend of $0.248 per share. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.24. This represents a $0.99 annualized dividend and a yield of 0.69%. The ex-dividend date of this dividend is Tuesday, December 31st. Agilent Technologies’s dividend payout ratio (DPR) is 22.40%.

Wall Street Analysts Forecast Growth

A has been the topic of a number of recent research reports. Barclays dropped their target price on Agilent Technologies from $145.00 to $135.00 and set an “underweight” rating on the stock in a report on Wednesday, November 27th. Evercore ISI boosted their price objective on shares of Agilent Technologies from $135.00 to $145.00 and gave the company an “in-line” rating in a research note on Tuesday, October 1st. Wells Fargo & Company reduced their target price on shares of Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating for the company in a research note on Monday, December 9th. Citigroup lifted their target price on shares of Agilent Technologies to $165.00 and gave the company a “buy” rating in a report on Thursday, December 19th. Finally, Sanford C. Bernstein cut their price target on shares of Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating for the company in a report on Tuesday, November 26th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and eight have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $143.62.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.